Aoife Courtney, Lok Yi Joyce Tan, Ali Elsheikh, Faye O'Donovan, Iman Faez, Rachel Riegel, Tara O'Sullivan, Antoinette Tuthill, Oratile Kgosidialwa
{"title":"Characteristics, management and outcomes of patients with hyponatraemia presenting to an Irish tertiary hospital.","authors":"Aoife Courtney, Lok Yi Joyce Tan, Ali Elsheikh, Faye O'Donovan, Iman Faez, Rachel Riegel, Tara O'Sullivan, Antoinette Tuthill, Oratile Kgosidialwa","doi":"10.1530/EC-24-0666","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hyponatraemia is the most common electrolyte abnormality in clinical practice and is associated with increased in-hospital mortality and length of stay (LOS). The aims of this study were to evaluate the prevalence of hyponatraemia in adult medical inpatients; compliance with consensus guidelines regarding evaluation and management of hyponatraemia; and LOS and mortality.</p><p><strong>Design: </strong>This was a retrospective single-centre observational study conducted in a tertiary-level Irish hospital.</p><p><strong>Methods: </strong>Adult patients admitted under the medical services over a two-month period with a serum sodium (sNa) <135mmol/L were included. Patients were classified according to nadir sNa during their admission; mild, moderate and severe hyponatraemia defined as a sNa between 130-134mmol/L, 125-129mmol/L and <125mmol/L respectively. Clinical information was gathered retrospectively.</p><p><strong>Results: </strong>486 patient episodes of hyponatraemia were included. The prevalence of hyponatraemia was 32.9%.The median age was 78 (min-max:16-100) years and 239 (49.0%) were female. The median nadir sNa was 132 (min-max:105-143)mmol/L. Eighty-seven (17.9%) and 48 (9.9%) patients had moderate and severe hyponatraemia. In cases of moderate and severe hyponatraemia, the most common cause of hyponatraemia was hypovolaemia (n=33, 24.4%). Ninety-one patients (67.4%) with moderate and severe hyponatraemia had active treatment of hyponatraemia and 33 (24.4%) had input from a specialist service. The mean LOS was 15.0 (±22.5), 19.3 (±21.7) and 21.2 (±45.5) (p=0.01) days in mild, moderate and severe hyponatraemia respectively. Overall inpatient mortality was 7.0% (n=34).</p><p><strong>Conclusions: </strong>Hyponatraemia is often incompletely investigated, suboptimally managed with insufficient input from specialist services sought in a large tertiary hospital. Hyponatraemia therefore represents a potential intervention target to reduce inpatient morbidity, mortality and healthcare costs.</p>","PeriodicalId":11634,"journal":{"name":"Endocrine Connections","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Connections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1530/EC-24-0666","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Hyponatraemia is the most common electrolyte abnormality in clinical practice and is associated with increased in-hospital mortality and length of stay (LOS). The aims of this study were to evaluate the prevalence of hyponatraemia in adult medical inpatients; compliance with consensus guidelines regarding evaluation and management of hyponatraemia; and LOS and mortality.
Design: This was a retrospective single-centre observational study conducted in a tertiary-level Irish hospital.
Methods: Adult patients admitted under the medical services over a two-month period with a serum sodium (sNa) <135mmol/L were included. Patients were classified according to nadir sNa during their admission; mild, moderate and severe hyponatraemia defined as a sNa between 130-134mmol/L, 125-129mmol/L and <125mmol/L respectively. Clinical information was gathered retrospectively.
Results: 486 patient episodes of hyponatraemia were included. The prevalence of hyponatraemia was 32.9%.The median age was 78 (min-max:16-100) years and 239 (49.0%) were female. The median nadir sNa was 132 (min-max:105-143)mmol/L. Eighty-seven (17.9%) and 48 (9.9%) patients had moderate and severe hyponatraemia. In cases of moderate and severe hyponatraemia, the most common cause of hyponatraemia was hypovolaemia (n=33, 24.4%). Ninety-one patients (67.4%) with moderate and severe hyponatraemia had active treatment of hyponatraemia and 33 (24.4%) had input from a specialist service. The mean LOS was 15.0 (±22.5), 19.3 (±21.7) and 21.2 (±45.5) (p=0.01) days in mild, moderate and severe hyponatraemia respectively. Overall inpatient mortality was 7.0% (n=34).
Conclusions: Hyponatraemia is often incompletely investigated, suboptimally managed with insufficient input from specialist services sought in a large tertiary hospital. Hyponatraemia therefore represents a potential intervention target to reduce inpatient morbidity, mortality and healthcare costs.
期刊介绍:
Endocrine Connections publishes original quality research and reviews in all areas of endocrinology, including papers that deal with non-classical tissues as source or targets of hormones and endocrine papers that have relevance to endocrine-related and intersecting disciplines and the wider biomedical community.